SBI Securities’s Century Therapeutics IPSC Stock Holding History

SBI Securities’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.98K	Sell	1,218 -42	-3%	-$96	﹤0.01%	2407
2026 Q1	$2.85K	Sell	1,260 -270	-18%	-$568	﹤0.01%	2283
2025 Q4	$1.52K	Hold	1,530	–	–	﹤0.01%	2495
2025 Q3	$762	Hold	1,530	–	–	﹤0.01%	2807
2025 Q2	$855	Buy	1,530 +400	+35%	+$215	﹤0.01%	2751
2025 Q1	$538	Buy	1,130 +850	+304%	+$639	﹤0.01%	2843
2024 Q4	$283	Buy	+280	New	+$381	﹤0.01%	3113

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SBI Securities's IPSC Position: Q2 2026 in Review

SBI Securities reduced its Century Therapeutics (IPSC) stake by 3.3% in Q2 2026, selling an estimated $96 and leaving 1,218 shares worth $2.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

SBI Securities first reported a position in IPSC in Q4 2024 and has held it in 7 quarters since. 6 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

SBI Securities held 1,218 shares of Century Therapeutics worth $2.98K as of Q2 2026.
SBI Securities sold 42 Century Therapeutics shares in Q2 2026, an estimated $96.
Century Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2407 holding.
SBI Securities first reported a position in Century Therapeutics in Q4 2024 and has held it in 7 quarters since.
6 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.